How People, Process and Tools can Improve Clinical Trial Quality
Duration: 1 hour
Many pharmaceutical companies are excited by the promise of Risk-Based Monitoring, but are uncertain as to how to implement such an initiative. In this insightful presentation, Courtney McBean will discuss the core principles of Risk-Based Monitoring and the key steps to Implementing an RBM program that goes beyond reducing site visits and instills a greater focus on quality in clinical trials.
The presentation will focus on the important role played by
- People – Having the right people involved in your program is a must!
- Process – Defining a repeatable plan is crucial – learn the 7 points that must be considered
- Tools – Attendees will see firsthand how the right technology can help you monitor what matters, when it matters.
This is a must-see for any sponsor or CRO seeking to reduce costs, improve quality, and run more efficient clinical trials.
Courtney McBean is the Vice President of Clinical Innovation at BioClinica. She was a founder of Blueprint Clinical – the innovative company that created the Compass Intelligent Monitoring solution and was recognized by Gartner as a "2014 Cool Vendor in Life Sciences." Since BioClinica's May acquisition of Blueprint, Courtney and her team have doubled their efforts to challenge the pharmaceutical community to go beyond risk-based monitoring and embrace an Intelligent Monitoring approach to clinical trials that goes beyond reducing site monitoring visits to a focus on overall quality.